Harbor Investment Advisory’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.4K Hold
150
﹤0.01% 1012
2026
Q1
$11.9K Sell
150
-1,125
-88% -$90.9K ﹤0.01% 883
2025
Q4
$105K Buy
1,275
+1,125
+750% +$87K 0.01% 504
2025
Q3
$10.5K Hold
150
﹤0.01% 899
2025
Q2
$9.62K Hold
150
﹤0.01% 892
2025
Q1
$9.52K Hold
150
﹤0.01% 878
2024
Q4
$9.98K Hold
150
﹤0.01% 873
2024
Q3
$10.5K Hold
150
﹤0.01% 861
2024
Q2
$9.72K Hold
150
﹤0.01% 862
2024
Q1
$9.71K Hold
150
﹤0.01% 859
2023
Q4
$9.88K Hold
150
﹤0.01% 832
2023
Q3
$8.56K Hold
150
﹤0.01% 841
2023
Q2
$9.19K Hold
150
﹤0.01% 1039
2023
Q1
$9.41K Sell
150
-30
-17% -$1.93K ﹤0.01% 1041
2022
Q4
$11.4K Hold
180
﹤0.01% 996
2022
Q3
$11K Hold
180
﹤0.01% 1027
2022
Q2
$10K Hold
180
﹤0.01% 1036
2022
Q1
$11K Hold
180
﹤0.01% 1039
2021
Q4
$13K Hold
180
﹤0.01% 1017
2021
Q3
$13K Hold
180
﹤0.01% 1015
2021
Q2
$14K Hold
180
﹤0.01% 959
2021
Q1
$13K Sell
180
-20
-10% -$1.51K ﹤0.01% 940
2020
Q4
$14K Hold
200
﹤0.01% 877
2020
Q3
$11K Hold
200
﹤0.01% 839
2020
Q2
$12K Hold
200
﹤0.01% 749
2020
Q1
$9K Hold
200
﹤0.01% 769
2019
Q4
$11K Buy
+200
New +$10.4K ﹤0.01% 621

Other funds holding PBE

Harbor Investment Advisory's PBE Position: Q2 2026 in Review

Harbor Investment Advisory held its Invesco Biotechnology & Genome ETF (PBE) position steady in Q2 2026 at 150 shares worth $13.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1012.

Harbor Investment Advisory first reported a position in PBE in Q4 2019 and has held it in 27 quarters since. The position peaked at $105K in Q4 2025. 31 funds tracked by Wall St. Rank hold PBE as of Q2 2026.

  • Harbor Investment Advisory held 150 shares of Invesco Biotechnology & Genome ETF worth $13.4K as of Q2 2026.
  • Harbor Investment Advisory left its Invesco Biotechnology & Genome ETF share count unchanged in Q2 2026.
  • Invesco Biotechnology & Genome ETF made up ﹤0.01% of Harbor Investment Advisory's portfolio in Q2 2026, its #1012 holding.
  • Harbor Investment Advisory first reported a position in Invesco Biotechnology & Genome ETF in Q4 2019 and has held it in 27 quarters since.
  • Harbor Investment Advisory's Invesco Biotechnology & Genome ETF position peaked at $105K in Q4 2025.
  • 31 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q2 2026.

Based on Harbor Investment Advisory's 13F filing for Q2 2026, filed 7 Jul 2026.